Chapter 21 : Multiple Myeloma and Related Plasma cell Disorders Flashcards

1
Q

Fill in the blanks. “ _____________ reflects the increased synthesis of a specific type of immunoglobulin from a single expanded clone of plasma cells.”

A

A monoclonal immunoglobulin band (M-protein), or paraprotein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Fill in the blanks. “ When a monoclonal antibody is detected in the blood it is called __________.”

A

Paraproteinaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Multiple myeloma?

A

Multiple myeloma, also termed plasma cell myeloma, is a neoplastic disease characterized by plasma cell accumulation in the bone marrow , the presence of monoclonal protein in the serum or urine or both and in symptomatic patients related tissue damage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the peak age incidence for Multiple myeloma?

A

65 - 70 years old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the pathogenesis of Multiple myeloma?

A

The myeloma neoplastic cell is a POST - GERMINAL CENTRE plasma cell that has undergone immunoglobulin class switching and somatic hypermutation and secretes the paraprotein that is present in serum.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the most frequent finding of clonal rearrange heavy and light chains immunoglobulins in multiple Myeloma?

A

Translocations involving the heavy chain on chromosome 14q

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What genetic mutations are considered EARLY Unifying genetic events associated with Multiple myeloma?

A

Dysregulated or increased expression of the cyclin D1, D2 or D3 genes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What genetic mutations are considered LATER Unifying genetic events associated with Multiple myeloma?

A

Secondary translocations of MYC, point mutations, e.g. of RAS or TP53, deletions, e.g. TP53, or epigenetic abnormalities.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

True or False? Multiple Myeloma is most common in people of European descent.

A

FALSE!! It is most common in people of African Descent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Fill in the blanks. “ In Multiple myeloma , Osteolytic lesions are caused by osteoclast activation resulting from high serum levels of ___________.”

A

Nuclear factor-κB (NF-κB) ligand (RANKL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nuclear factor-κB (NF-κB) ligand (RANKL) is produced by which cells?

A

Plasma cells and bone marrow stroma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When does a Asymptomatic or Smouldering Myeloma increases its risk of becoming Symptomatic myeloma?

A
  1. If there is more than 60% of plasma cells in the marrow
  2. If there are circulating plasma cells
  3. If there is a greatly unbalanced free light chain ratio
  4. If there are Focal lesions on MRI
  5. If there are any cytogenetic abnormalities.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When is symptomatic myeloma diagnosed?

A
  1. If there is a Monoclonal protein in serum, urine, or both .
  2. Increased clonal plasma cells in the bone marrow
  3. Disease-related organ or tissue impairment.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the clinical features of Multiple Myeloma ?

A

C - Hypercalcaemia
R - Renal impairment
A - Anaemia
B - Bone disease

Additionally,

  • Recurrent infections
  • Abnormal bleeding tendency
  • Amyloidosis (light chain) occurs in 5% with features such as macroglossia, carpal tunnel syndrome, heart failure, peri-orbital purpura and diarrhoea.
  • Hyperviscosity syndrome, with purpura, haemorrhages, visual changes, cen- tral nervous system (CNS) symptoms, neuropathies and heart failure.
  • Deep Vein Thrombosis
  • Peripheral Neuropathy
  • PUNCHED OUT LESIONS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the Laboratory Findings in Multiple Myeloma?

A
  1. Presence of a paraprotein- IgG (60%) , IgA(20%) & Light chain only ( The rest ) , less than 1% IgD & IgE
  2. Elevated serum immunoglobulin free light chains.
  3. Immunoparesis ( Normal serum immunoglobulin levels (IgG, IgA and IgM) are reduced)
  4. BENCE JONES Proteins
  5. There is usually a normochromic normocytic or macrocytic anaemia.
  6. ROULEAUX formation
  7. Neutropenia & Thrombocytopenia
  8. Abnormal Plasma cells
  9. High ESR - due to reduction in the normal red cell–repelling ‘zeta potential’ by immunoglobulin coating of erythrocyte surfaces.
  10. More than 20% of marrow cells in bone marrow
  11. Malignant plasma cells CD38 positive, CD 138 positive & LOW CD45
  12. Bone lesions
  13. Increase in Serum Calcium
  14. Increase in Serum Creatinine
  15. Normal ALP - except following pathological fractures.
  16. Increase LDH
  17. LOW Serum Albumin occurs with advanced disease = poor prognosis
  18. Raised Serum β2-microglobulin = poor outcome if high
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Fill in the blanks. “ ________________ is new sensitive method of measuring paraproteins and free light chains.”

A

Mass Spectrometry

17
Q

Fill in the blanks. “ _____________ is useful in the diagnosis and monitoring of myeloma and other forms of malignant paraproteinaemia.”

A

Serum free light chain assay

18
Q

Where is Free light free chains excreted?

A

They are excreted into the urine.

19
Q

How can abnormal plasma cells be detected in Multiple Myeloma?

A

Sensitive flow cytometry

20
Q

What is the immunophenotype of malignant plasma cells?

A

CD38 +
CD138 +
CD45 Low

21
Q

Which test is used to measure the number of plasma cells in the marrow biopsy?

A

Anti-CD138

22
Q

Which drug must be avoided in patients who are potential SCT candidates because prolonged use makes stem cells more difficult to harvest?

A

Alkylating agents such as Melphalan

23
Q

What are the clinical features of Plasma cell leukaemia?

A

The clinical features tend to be a combination of those found in acute leukaemia (pancytopenia and organomegaly) with features of myeloma (hypercalcaemia, renal involvement and bone disease).

24
Q

What are the common drug combinations for patients who are Transplant candidates?

A

■ VRD or RVD – bortezomib (Velcade), lenalidomide
(Revlimid) and dexamethasone.
■ KRD – carfilzomib (Kyprolis), lenalidomide and
dexamethasone.
■ IRD – ixazomib, lenalidomide and dexamethasone.

25
Q

What are the Clinical features of POEMS syndrome?

A
  • Splenomegaly
  • Hepatomegaly or lymphadenopathy
  • Extravascular fluid overload
  • Endocrine abnormalities, skin changes or Castleman disease.
26
Q

An elevated level of Vascular Endothelial Growth Factor (VEGF) is present in which pathology?

A

Multiple Myeloma

27
Q
A